Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
It focuses on cellular metabolic regulation and energy remodeling, and differs from conventional metabolic regulators by featuring a defined target and stable efficacy.By specifically inhibiting nicotinamide Nmethyltransferase (NNMT), this product blocks excessive NAD+ consumption, increases intracellular NAD+ levels, enhances mitochondrial function and fatty acid oxidation efficiency, and improves glucose metabolism and insulin sensitivity
PMID 18020969
This method bypasses the digestive system, making it ideal for people who: Have trouble absorbing B12 due to gastrointestinal issues (like Crohns disease or coeliac disease) Are on medications that interfere with B12 absorption (like metformin or anti-acids) Follow vegan or vegetarian diets Have undergone gastric surgery
A 2015 Cell Metabolism study that first characterized MOTS-c as a mitochondria-derived regulator of metabolic homeostasis capable of reducing obesity and insulin resistance in animal models was foundational in establishing this peptide class
Animal-to-human translation is uncertain
US$ 29.47
US$ 29.43
US$ 27.99
